Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity

Pancreatic stellate cells (PSCs) are typically activated in pancreatic ductal adenocarcinoma (PDAC) and release exosomes containing high levels of microRNA‑21 (miR‑21). However, the specific roles of exosomal miR‑21 in regulating the PDAC malignant phenotype remain unknown. The present study aimed t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of oncology 2020-04, Vol.56 (4), p.1025-1033
Hauptverfasser: Ma, Qiang, Wu, Huanwen, Xiao, Ying, Liang, Zhiyong, Liu, Tonghua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1033
container_issue 4
container_start_page 1025
container_title International journal of oncology
container_volume 56
creator Ma, Qiang
Wu, Huanwen
Xiao, Ying
Liang, Zhiyong
Liu, Tonghua
description Pancreatic stellate cells (PSCs) are typically activated in pancreatic ductal adenocarcinoma (PDAC) and release exosomes containing high levels of microRNA‑21 (miR‑21). However, the specific roles of exosomal miR‑21 in regulating the PDAC malignant phenotype remain unknown. The present study aimed to determine the effects of exosomal miR‑21 on the migratory ability of PDAC cells and explore the potential underlying molecular mechanism. Weighted gene correlation network and The Cancer Genome Atlas database analysis revealed that high miR‑21 levels were associated with a poor prognosis in patients with pancreatic adenocarcinoma, and that the Ras/ERK signaling pathway may be a potential target of miR‑21. In vitro, PDAC cells were demonstrated to internalize the PSC-derived exosome, resulting in high miR‑21 levels, which subsequently promoted cell migration, induced epithelial‑to‑mesenchymal transition (EMT) and increased matrix metalloproteinase‑2/9 activity. In addition, exosomal miR‑21 increased the levels of ERK1/2 and Akt phosphorylation in PDAC cells. Collectively, these results suggested that PSC‑derived exosomal miR‑21 may promote PDAC cell migration and EMT and enhance Ras/ERK signaling activity. Thus, miR‑21 may be a potential cause of poor prognosis in patients with pancreatic cancer and a new treatment target.
doi_str_mv 10.3892/ijo.2020.4986
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2371278886</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A619214941</galeid><sourcerecordid>A619214941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-dfb6f105472d50e0e04d48d1f898b9e17e23e149a02d4fd8e2e1b51c74b198983</originalsourceid><addsrcrecordid>eNptks1u1DAQxyMEoqVw5IosIXHL1nacxD6uqvIhKpBW9Gw5zmTXqyRebKewN14B8YY8CZNuPyU0hxnZv5mxZ_5Z9prRRSEVP3Vbv-CU04VQsnqSHbNasZwLXjzFmDKVV6JQR9mLGLeU8rKk7Hl2VPCCqbKUx9mfy12A9dSb5PxIfEfgp49-MD0ZnA1-9WX599dvzogbyc6MNgCClsQEPaYAsegj2QU_-ATxIWIxhHANYKl1ODQwY0tg3Mx3kaxMPD1ffcastPlh9sTY5K5c2r_MnnWmj_Dqxp9kl-_Pv519zC--fvh0trzIrShlytuuqTpGS1HztqSAJlohW9ZJJRsFrAZeABPKUN6KrpXAgTUls7VomEKmOMneHuri-79PEJPe-imM2FLzoma8llJW99Ta9KDd2PkUjB1ctHpZMcWxg2BILf5DobWAg_QjdA7PHyW8e5CwAdOnTfT9NI8pPgbzA4jriDFAp3fBDSbsNaN6loBGCehZAnqWAPJvbn41NQO0d_Ttzot_V-StGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2371278886</pqid></control><display><type>article</type><title>Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ma, Qiang ; Wu, Huanwen ; Xiao, Ying ; Liang, Zhiyong ; Liu, Tonghua</creator><creatorcontrib>Ma, Qiang ; Wu, Huanwen ; Xiao, Ying ; Liang, Zhiyong ; Liu, Tonghua</creatorcontrib><description>Pancreatic stellate cells (PSCs) are typically activated in pancreatic ductal adenocarcinoma (PDAC) and release exosomes containing high levels of microRNA‑21 (miR‑21). However, the specific roles of exosomal miR‑21 in regulating the PDAC malignant phenotype remain unknown. The present study aimed to determine the effects of exosomal miR‑21 on the migratory ability of PDAC cells and explore the potential underlying molecular mechanism. Weighted gene correlation network and The Cancer Genome Atlas database analysis revealed that high miR‑21 levels were associated with a poor prognosis in patients with pancreatic adenocarcinoma, and that the Ras/ERK signaling pathway may be a potential target of miR‑21. In vitro, PDAC cells were demonstrated to internalize the PSC-derived exosome, resulting in high miR‑21 levels, which subsequently promoted cell migration, induced epithelial‑to‑mesenchymal transition (EMT) and increased matrix metalloproteinase‑2/9 activity. In addition, exosomal miR‑21 increased the levels of ERK1/2 and Akt phosphorylation in PDAC cells. Collectively, these results suggested that PSC‑derived exosomal miR‑21 may promote PDAC cell migration and EMT and enhance Ras/ERK signaling activity. Thus, miR‑21 may be a potential cause of poor prognosis in patients with pancreatic cancer and a new treatment target.</description><identifier>ISSN: 1019-6439</identifier><identifier>EISSN: 1791-2423</identifier><identifier>DOI: 10.3892/ijo.2020.4986</identifier><identifier>PMID: 32319558</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Adenocarcinoma ; Cancer genetics ; Cancer metastasis ; Cell adhesion &amp; migration ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Development and progression ; Electric wire and cable industry ; Epithelial-Mesenchymal Transition ; Exosomes - genetics ; Exosomes - metabolism ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genes ; Genetic aspects ; Genomes ; Genomics ; Humans ; MAP Kinase Signaling System ; Metastasis ; MicroRNA ; MicroRNAs ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Microscopy ; Pancreatic cancer ; Pancreatic Neoplasms - genetics ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - pathology ; Pancreatic Stellate Cells - metabolism ; Pancreatic Stellate Cells - pathology ; Penicillin ; Prognosis ; Proto-Oncogene Proteins p21(ras) - metabolism ; Scientific equipment industry ; Signal Transduction ; Software ; Stem cells ; Up-Regulation ; Wound healing</subject><ispartof>International journal of oncology, 2020-04, Vol.56 (4), p.1025-1033</ispartof><rights>COPYRIGHT 2020 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-dfb6f105472d50e0e04d48d1f898b9e17e23e149a02d4fd8e2e1b51c74b198983</citedby><cites>FETCH-LOGICAL-c458t-dfb6f105472d50e0e04d48d1f898b9e17e23e149a02d4fd8e2e1b51c74b198983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32319558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Qiang</creatorcontrib><creatorcontrib>Wu, Huanwen</creatorcontrib><creatorcontrib>Xiao, Ying</creatorcontrib><creatorcontrib>Liang, Zhiyong</creatorcontrib><creatorcontrib>Liu, Tonghua</creatorcontrib><title>Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity</title><title>International journal of oncology</title><addtitle>Int J Oncol</addtitle><description>Pancreatic stellate cells (PSCs) are typically activated in pancreatic ductal adenocarcinoma (PDAC) and release exosomes containing high levels of microRNA‑21 (miR‑21). However, the specific roles of exosomal miR‑21 in regulating the PDAC malignant phenotype remain unknown. The present study aimed to determine the effects of exosomal miR‑21 on the migratory ability of PDAC cells and explore the potential underlying molecular mechanism. Weighted gene correlation network and The Cancer Genome Atlas database analysis revealed that high miR‑21 levels were associated with a poor prognosis in patients with pancreatic adenocarcinoma, and that the Ras/ERK signaling pathway may be a potential target of miR‑21. In vitro, PDAC cells were demonstrated to internalize the PSC-derived exosome, resulting in high miR‑21 levels, which subsequently promoted cell migration, induced epithelial‑to‑mesenchymal transition (EMT) and increased matrix metalloproteinase‑2/9 activity. In addition, exosomal miR‑21 increased the levels of ERK1/2 and Akt phosphorylation in PDAC cells. Collectively, these results suggested that PSC‑derived exosomal miR‑21 may promote PDAC cell migration and EMT and enhance Ras/ERK signaling activity. Thus, miR‑21 may be a potential cause of poor prognosis in patients with pancreatic cancer and a new treatment target.</description><subject>Adenocarcinoma</subject><subject>Cancer genetics</subject><subject>Cancer metastasis</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Cell Proliferation</subject><subject>Development and progression</subject><subject>Electric wire and cable industry</subject><subject>Epithelial-Mesenchymal Transition</subject><subject>Exosomes - genetics</subject><subject>Exosomes - metabolism</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Humans</subject><subject>MAP Kinase Signaling System</subject><subject>Metastasis</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Microscopy</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - genetics</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Stellate Cells - metabolism</subject><subject>Pancreatic Stellate Cells - pathology</subject><subject>Penicillin</subject><subject>Prognosis</subject><subject>Proto-Oncogene Proteins p21(ras) - metabolism</subject><subject>Scientific equipment industry</subject><subject>Signal Transduction</subject><subject>Software</subject><subject>Stem cells</subject><subject>Up-Regulation</subject><subject>Wound healing</subject><issn>1019-6439</issn><issn>1791-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptks1u1DAQxyMEoqVw5IosIXHL1nacxD6uqvIhKpBW9Gw5zmTXqyRebKewN14B8YY8CZNuPyU0hxnZv5mxZ_5Z9prRRSEVP3Vbv-CU04VQsnqSHbNasZwLXjzFmDKVV6JQR9mLGLeU8rKk7Hl2VPCCqbKUx9mfy12A9dSb5PxIfEfgp49-MD0ZnA1-9WX599dvzogbyc6MNgCClsQEPaYAsegj2QU_-ATxIWIxhHANYKl1ODQwY0tg3Mx3kaxMPD1ffcastPlh9sTY5K5c2r_MnnWmj_Dqxp9kl-_Pv519zC--fvh0trzIrShlytuuqTpGS1HztqSAJlohW9ZJJRsFrAZeABPKUN6KrpXAgTUls7VomEKmOMneHuri-79PEJPe-imM2FLzoma8llJW99Ta9KDd2PkUjB1ctHpZMcWxg2BILf5DobWAg_QjdA7PHyW8e5CwAdOnTfT9NI8pPgbzA4jriDFAp3fBDSbsNaN6loBGCehZAnqWAPJvbn41NQO0d_Ttzot_V-StGw</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Ma, Qiang</creator><creator>Wu, Huanwen</creator><creator>Xiao, Ying</creator><creator>Liang, Zhiyong</creator><creator>Liu, Tonghua</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200401</creationdate><title>Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity</title><author>Ma, Qiang ; Wu, Huanwen ; Xiao, Ying ; Liang, Zhiyong ; Liu, Tonghua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-dfb6f105472d50e0e04d48d1f898b9e17e23e149a02d4fd8e2e1b51c74b198983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma</topic><topic>Cancer genetics</topic><topic>Cancer metastasis</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Cell Proliferation</topic><topic>Development and progression</topic><topic>Electric wire and cable industry</topic><topic>Epithelial-Mesenchymal Transition</topic><topic>Exosomes - genetics</topic><topic>Exosomes - metabolism</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Humans</topic><topic>MAP Kinase Signaling System</topic><topic>Metastasis</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Microscopy</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - genetics</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Stellate Cells - metabolism</topic><topic>Pancreatic Stellate Cells - pathology</topic><topic>Penicillin</topic><topic>Prognosis</topic><topic>Proto-Oncogene Proteins p21(ras) - metabolism</topic><topic>Scientific equipment industry</topic><topic>Signal Transduction</topic><topic>Software</topic><topic>Stem cells</topic><topic>Up-Regulation</topic><topic>Wound healing</topic><toplevel>online_resources</toplevel><creatorcontrib>Ma, Qiang</creatorcontrib><creatorcontrib>Wu, Huanwen</creatorcontrib><creatorcontrib>Xiao, Ying</creatorcontrib><creatorcontrib>Liang, Zhiyong</creatorcontrib><creatorcontrib>Liu, Tonghua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Qiang</au><au>Wu, Huanwen</au><au>Xiao, Ying</au><au>Liang, Zhiyong</au><au>Liu, Tonghua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity</atitle><jtitle>International journal of oncology</jtitle><addtitle>Int J Oncol</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>56</volume><issue>4</issue><spage>1025</spage><epage>1033</epage><pages>1025-1033</pages><issn>1019-6439</issn><eissn>1791-2423</eissn><abstract>Pancreatic stellate cells (PSCs) are typically activated in pancreatic ductal adenocarcinoma (PDAC) and release exosomes containing high levels of microRNA‑21 (miR‑21). However, the specific roles of exosomal miR‑21 in regulating the PDAC malignant phenotype remain unknown. The present study aimed to determine the effects of exosomal miR‑21 on the migratory ability of PDAC cells and explore the potential underlying molecular mechanism. Weighted gene correlation network and The Cancer Genome Atlas database analysis revealed that high miR‑21 levels were associated with a poor prognosis in patients with pancreatic adenocarcinoma, and that the Ras/ERK signaling pathway may be a potential target of miR‑21. In vitro, PDAC cells were demonstrated to internalize the PSC-derived exosome, resulting in high miR‑21 levels, which subsequently promoted cell migration, induced epithelial‑to‑mesenchymal transition (EMT) and increased matrix metalloproteinase‑2/9 activity. In addition, exosomal miR‑21 increased the levels of ERK1/2 and Akt phosphorylation in PDAC cells. Collectively, these results suggested that PSC‑derived exosomal miR‑21 may promote PDAC cell migration and EMT and enhance Ras/ERK signaling activity. Thus, miR‑21 may be a potential cause of poor prognosis in patients with pancreatic cancer and a new treatment target.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>32319558</pmid><doi>10.3892/ijo.2020.4986</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1019-6439
ispartof International journal of oncology, 2020-04, Vol.56 (4), p.1025-1033
issn 1019-6439
1791-2423
language eng
recordid cdi_proquest_journals_2371278886
source Spandidos Publications Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adenocarcinoma
Cancer genetics
Cancer metastasis
Cell adhesion & migration
Cell Line, Tumor
Cell Movement
Cell Proliferation
Development and progression
Electric wire and cable industry
Epithelial-Mesenchymal Transition
Exosomes - genetics
Exosomes - metabolism
Gene expression
Gene Expression Regulation, Neoplastic
Genes
Genetic aspects
Genomes
Genomics
Humans
MAP Kinase Signaling System
Metastasis
MicroRNA
MicroRNAs
MicroRNAs - genetics
MicroRNAs - metabolism
Microscopy
Pancreatic cancer
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
Pancreatic Stellate Cells - metabolism
Pancreatic Stellate Cells - pathology
Penicillin
Prognosis
Proto-Oncogene Proteins p21(ras) - metabolism
Scientific equipment industry
Signal Transduction
Software
Stem cells
Up-Regulation
Wound healing
title Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A00%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upregulation%20of%20exosomal%20microRNA%E2%80%9121%20in%20pancreatic%20stellate%20cells%20promotes%20pancreatic%20cancer%20cell%20migration%20and%20enhances%20Ras/ERK%20pathway%20activity&rft.jtitle=International%20journal%20of%20oncology&rft.au=Ma,%20Qiang&rft.date=2020-04-01&rft.volume=56&rft.issue=4&rft.spage=1025&rft.epage=1033&rft.pages=1025-1033&rft.issn=1019-6439&rft.eissn=1791-2423&rft_id=info:doi/10.3892/ijo.2020.4986&rft_dat=%3Cgale_proqu%3EA619214941%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2371278886&rft_id=info:pmid/32319558&rft_galeid=A619214941&rfr_iscdi=true